Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : MYSYF: Mercury Scheduling Systems (software) -- Ignore unavailable to you. Want to Upgrade?

To: WTSherman who wrote (2)	3/11/2000 1:26:00 PM
From: Marshall	Read Replies (1) \| Respond to of 23

Probably several things to consider there, especially what actually qualifies as R&D expense after your products begin selling. Anyone know "the rules" on this and are things reported on a different basis in Canada? For instance software development is bound to be mainly composed of internal labor and "no charge" beta installations, how much of this would be classified more as an R&D expense then but cost of products sold later? Looking through their website it does appear that they've got a pretty full product suite offering assembled. Since they no longer classify themselves as being in the R&D stage I'd think sales would take precedence for a while and since they now have the core programs developed future upgrades and enhancements may not constitute anywhere near the same initial development expenses.